{
    "2019-07-10": [
        [
            {
                "time": "",
                "original_text": "复星医药(02196)为复星实业(香港)5000万美元贷款提供担保 大额借贷担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复星实业",
                        "贷款担保",
                        "5000万美元"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(02196.HK)向子公司提供不超5000万美元担保 大额借贷担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "担保",
                        "5000万美元"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "7月10日",
                "original_text": "A股市场资金变动一览（7月10日）",
                "features": {
                    "keywords": [
                        "A股",
                        "资金变动"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "布局乙肝药品生产线，复星医药大涨6%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "乙肝药品",
                        "生产线",
                        "大涨6%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "6月",
                "original_text": "6月医药大事件之榜单篇：多样性排名考验药企综合实力",
                "features": {
                    "keywords": [
                        "医药",
                        "大事件",
                        "榜单",
                        "综合实力"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "港股异动︱收购葛兰素史克苏州公司布局乙肝药品生产线 复星医药(02196)反弹逾4%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "葛兰素史克",
                        "乙肝药品",
                        "生产线",
                        "反弹4%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股异动 | 复星医药涨超4% 子公司获乙肝药品生产线",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "乙肝药品",
                        "生产线",
                        "涨超4%"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股医药板块迅速走高 吉林长龙药业涨近5%",
                "features": {
                    "keywords": [
                        "港股",
                        "医药板块",
                        "走高",
                        "吉林长龙药业",
                        "涨近5%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股异动 | 药品股普涨 改革持续推进 获券商看好",
                "features": {
                    "keywords": [
                        "港股",
                        "药品股",
                        "普涨",
                        "改革",
                        "券商看好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "公告解读：中国平安耗资逾5亿元回购股份 累计回购金额己达50亿元",
                "features": {
                    "keywords": [
                        "中国平安",
                        "回购股份",
                        "5亿元",
                        "累计回购50亿元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}